On June 09, 2014, Bristol-Myers Squibb Co (NYSE:BMY), named Giovanni Caforio as its chief operating officer, and was elected to the board, effective June 5, 2014. Bristol-Myers Squibb Co (NYSE:BMY), net profit margin is 17.70% and weekly performance is -1.18%. On last trading day company shares ended up $46.96. Analysts mean target price for the company is $54.76. Bristol-Myers Squibb Co (NYSE:BMY), distance from 50-day simple moving average (SMA50) is -5.45%.
AstraZeneca plc (ADR) (NYSE:AZN), will pay $7.25 million up front and now takes over development of SNG001, an inhaled formulation of interferon beta. The rest of the money will follow in milestones up to commercialization, with tiered royalties to come on commercial sales. AstraZeneca plc (ADR) (NYSE:AZN), advanced 1.95% in last trading session and ended the day on $74.22. AZN, Gross Margin is 79.80% and its return on assets is 3.70%. AstraZeneca plc (ADR) (NYSE:AZN), quarterly performance is 11.32%.
Provectus Biopharmaceuticals Inc (NYSEMKT:PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced that it will hold a conference call on Thursday, June 19, 2014, at 4 pm Eastern Daylight Time. Provectus Biopharmaceuticals Inc (NYSEMKT:PVCT), shares moved up 25.51% in last trading session and was closed at $1.23, while trading in range of $0.98 – 1.25. Provectus Biopharmaceuticals Inc (NYSEMKT:PVCT), year to date (YTD) performance is -48.96%.
AbbVie Inc (NYSE:ABBV), a biopharmaceutical company engaged in the research, development and selling of advanced therapies for complex diseases has recently announced the outcomes of the ALIGN study. The results of the study were presented in Paris at EULAR 2014 Congress. AbbVie Inc (NYSE:ABBV), ended the last trading day at $54.23. Company weekly volatility is calculated as 2.01% and price to cash ratio as 9.48. AbbVie Inc (NYSE:ABBV), showed a negative weekly performance of 4.43%.
Pfizer Inc. (NYSE:PFE), Chief Financial Officer Frank D’Amelio said the company’s $117 billion bid for AstraZeneca Plc (AZN) broke down over price. Pfizer Inc. (NYSE:PFE), net profit margin is 81.20% and weekly performance is -0.71%. On last trading day company shares ended up $29.43. Analysts mean target price for the company is $34.55. Pfizer Inc. (NYSE:PFE), distance from 50-day simple moving average (SMA50) is -2.15%.